Neurologic, Neurocognitive, and Cardiovascular Complications of Hypoparathyroidism

Dr. Shoback emphasizes that both the central and peripheral nervous systems are heavily involved. The spectrum ranges from subtle cognitive impairment—brain fog, memory difficulties, poor concentration, and reduced day-to-day functioning—to severe manifestations including generalized, focal, or absence seizures, and even obtundation or coma from critically low calcium. A less commonly recognized complication is a Parkinson's-like movement disorder seen in longstanding, poorly managed disease. She stresses that neuropsychiatric symptoms—brain fog, depression, anxiety—are often the most burdensome for patients, particularly middle-aged women managing jobs and families. Neuromuscular irritability frequently disrupts sleep, compounding functional impairment. She notes that symptoms can persist or progress even when biochemical labs appear acceptable, and that family members may notice cognitive decline before the patient or clinician does.

Regarding etiology, non-surgical genetic causes such as GATA3 loss-of-function mutations (Barakat syndrome), mitochondrial disorders, and other syndromic conditions carry additional neurologic burdens specific to their underlying diagnoses. Patients transitioning from pediatric to adult care often present with the sequelae of earlier developmental impairments.

Dr. Lubitz then explains that hypoparathyroidism is associated with adverse cardiac outcomes including arrhythmias, congestive heart failure, and cardiomyopathy, with calcium-phosphate imbalance contributing to vascular and cardiac valve calcification. She references a 2021 retrospective cohort study by Gosmanova using a large US managed care database of over 8,000 patients that demonstrated significantly elevated risks of myocardial infarction, stroke, peripheral vascular disease, atrial fibrillation, and non-ischemic heart failure. While EKGs are standard for monitoring QT prolongation in hypocalcemia, she notes that longer-term cardiovascular surveillance strategies remain to be defined.

In the next episode, "Musculoskeletal Complications of Hypoparathyroidism," Dr. Khosravi provides a detailed discussion of bone quality, fracture risk, the complexities of skeletal management, and how treatment choices must account for the unique low-bone-turnover state in hypoparathyroidism.